Patients with ovarian cancer may use a variety of medicines, such as targeted medicines, chemotherapy medicines, etc. When using these medicines, it is important to note the contraindications to their conversion.
Ovarian cancer patients have poor physical resistance, and cannot stop or reduce the dosage at will during the medication period, so as not to affect the treatment effect or even lead to aggravation of the disease. It is not allowed to increase or decrease the dosage of the drug without permission, nor can it change the medication time without permission, and the medication guidance of the doctor must be strictly followed.
Patients with ovarian cancer need to go to the hospital for regular reexaminations, such as CT, B-ultrasound, tumor markers, etc., to check the recovery of the body and whether the tumor has recurred. If the disease worsens or the tumor recurs, treatment should be carried out promptly.
Patients should avoid eating foods that may affect drug metabolism during the medication period to reduce the impact on drug metabolism.You can eat more high-protein foods (such as eggs, and milk), fresh fruits and vegetables (such as apples, and spinach), and iron-containing foods (such as animal liver, and spinach) to supplement nutrition and prevent anemia.
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:2012024-09-07
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medi···【more】
Recommended:1582025-13-01
Recent advancements have reaffirmed the significance of liquid biopsy in the management of advanced ···【more】
Recommended:1562025-06-01
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Food and Drug Administ···【more】
Recommended:1712024-30-12
The new indication involves the treatment of adult patients with locally advanced, unresectable non-···【more】
Recommended:1612024-24-12
he U.S. Food and Drug Administration (FDA) has approved Crenessity (crinecerfont) for use in combina···【more】
Recommended:1462024-17-12
In the phase Ib/II multicenter pivotal FELIX study, the autologous 41BB-ζ anti-CD19 chimeric antigen···【more】
Recommended:1052024-13-12
On 25 July 2024, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHM···【more】
Recommended:2482024-26-08
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: